From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease. - Prajapathi S; Mahajan K; Mohta A; Pradhan A (Journal of the American Heart Association, 2026)